Chronic Hepatitis C VirusNCT02629172
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
An observational study of Chronic Hepatitis C Virus, run by AbbVie at 388 sites in Japan.
Trial summary
The main objective of this study is to evaluate the safety and effectiveness of paritaprevir/ritonavir/ombitasvir used for patients infected with HCV genotype 1 in daily practice in Japan. Read more about this study
- Who is it for?
- Ages Up to 120 years
- Conditions the study is for
- Chronic Hepatitis C Virus
- How many people
- 3,043 participants
- Where
- 388 sitesJapan
- Study dates
- 5 Jan 2016to 28 Feb 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 120 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Chronic Hepatitis C
Who may be able to join
- HCV genotype 1 patients treated with paritaprevir/ritonavir/ombitasvir in daily practice
Who cannot join
- Patients who have been previously treated with paritaprevir/ritonavir/ombitasvir
Trial locations and contacts
388 sites in 1 country.
300 sites in 1 country
Japan300 sites
Ageo Central General Hospital /ID# 153002
Ageo, 362-0075
Sangane Clinic /ID# 162885
Aichi, 444-0124
Banbuntane Hotokukai Hospital /ID# 160909
Aichi, 454-8509
Masuda Family Clinic /ID# 155961
Aki-takata, 739-1101
Akita Kousei Medical Center /ID# 152183
Akita, 011-0948
Takahashi Naika /ID# 162888
Amagasaki, 660-0814
Kansai Rosai Hospital /ID# 152239
Amagasaki, 660-8511
Ikeda Hospital /ID# 152135
Amagasaki, 661-0002
Kato Michio Hepatology Clinic /ID# 152138
Amagasaki, Hyogo, 661-0012
Aomori Prefectural Central Hos /ID# 161749
Aomori, 030-8553
Konoe Hospital /ID# 158066
Arao, 864-0032
Japanese Red Cross Asahikawa /ID# 153552
Asahikawa, 070-0061
Asakura Medical Association Ho /ID# 152999
Asakura, 838-0069
Azumino Red Cross Hospital /ID# 160801
Azumino, 399-8205
Chiba Aoba Municipal Hospital /ID# 153016
Chiba, 260-0852
Chiba University Hospital /ID# 152988
Chiba, 260-8677
NHO Chiba-East-Hospital /ID# 152217
Chiba, 260-8712
Saisei Hospital /ID# 152277
Chiba, 262-8506
Fujishima Clinic /ID# 152216
Chiba, 299-4301
Seirei Sakura Citizen Hospital /ID# 152296
Chiba
Aioi Clinic /ID# 150059
Chichibu, 368-0026
Shonan Ishiguro Clinic /ID# 165272
Chigasaki, 253-0043
Shonan Tobu Sogo Hospital /ID# 152979
Chigasaki, 253-0083
Chikugo City Hospital /ID# 152318
Chikugo, 833-0041
Chitose City Hospital /ID# 156386
Chitose-shi
Tokyo Teishin Hospital /ID# 157457
Chiyoda-ku, Tokyo, 102-8798
University of Yamanashi Hospital /ID# 152164
Chuo-shi, Yamanashi, 409-3898
MIne Internal Medicine Clinic /ID# 155885
Fuchū, 183-0034
Tama Medical Center /ID# 158101
Fuchū, 183-8524
Fuji City General Hospital /ID# 159456
Fuji
Kusunoki Hospital /ID# 152072
Fujioka, Gunma, 3750024
Shonan Fujisawa Tokushukai Hospital /ID# 152967
Fujisawa-shi, Kanagawa, 251-0041
Fukuchiyama City Hospital /ID# 157455
Fukuchiyama
Fukui Prefectural Hospital /ID# 152137
Fukui, 910-0846
Fukui Prefectural Hospital /ID# 152976
Fukui, 910-0846
University of Fukui Hospital /ID# 152169
Fukui, 910-1104
Tanaka Internal Medical Clinic /ID# 157499
Fukui, 918-8055
NHO Kyushu Medical Center /ID# 153001
Fukuoka, Fukuoka, 810-8563
Fukuoka University Hospital /ID# 152272
Fukuoka, Fukuoka, 814-0180
Hopsital of the University of Occupational and Enviromental Health /ID# 152998
Fukuoka, 8078556
Saiseikai Fukuoka General Hosp /ID# 152167
Fukuoka, 810-0001
Fukuoka City Med Assoc Hosp /ID# 164143
Fukuoka, 814-8522
Shimizu Clinic /ID# 152166
Fukuoka, 815-0033
Chihaya Hospital /ID# 152223
Fukuoka
Fukushima Med Univ Hosp /ID# 154735
Fukushima, 960-1295
Clinic21 /ID# 153554
Fukushima, 960-8031
Rai Clinic /ID# 164133
Fukushima, 963-7769
Ishikawa Clinic /ID# 161747
Fukuyama, 720-1262
Morichika Internal Medicine /ID# 162887
Fukuyama, 721-0975
Fukuyama City Hospital /ID# 152322
Fukuyama-shi, Hiroshima, 721-8511
Gifu University Hospital /ID# 152993
Gifu, Gifu, 501-1194
Gifu Municipal Hospital /ID# 152283
Gifu, 500-8323
Haramachi Red Cross Hospital /ID# 157447
Gunma, 377-0801
Hospital Hakodate Hokkaido /ID# 159457
Hakodate, 041-0821
Hamamatsu University Hospital /ID# 154651
Hamamatsu, Shizuoka, 431-3125
Matsuda Internal Medicine /ID# 165064
Hamamatsu-shizuoka, 435-0028
Handa City Hospital /ID# 152140
Handa-shi, 475-0817
Mashiba Clinic /ID# 152097
Hannō, 357-0024
Hashima City Hospital /ID# 154658
Hashima, 501-6206
JA Hiroshima General Hospital /ID# 154729
Hatsukaichi
Higashihiroshima Medical Ctr /ID# 152970
Higashihiroshima, 739-0041
Mito Medical Center /ID# 154652
Higashiibaraki-gun, 311-3117
Higashi-Omi Keiai Hospital /ID# 164954
Higashiōmi, 527-0025
Higashiomicity Notogawa Hosp /ID# 152075
Higashiomi, Shiga, 521-1223
Wakakusa Daiichi Hospital /ID# 152201
Higashiosaka, 579-8056
Higashiosaka City General Hosp /ID# 153630
Higashiosaka-shi, 578-8588
Kousei Hospital /ID# 152159
Himeji, 670-0074
Kansai Medical University Hospital /ID# 152269
Hirakata-shi, Osaka, 573-1191
Kajihara Clinic /ID# 159451
Hiratsuka, 254-0077
Nakahata Gastroenterology Clin /ID# 164134
Hirosaki
Hirosaki University Hospital /ID# 153633
Hirosaki-aomori, 036-8203
Hiroshima Red Cross Hosp Atomi /ID# 152098
Hiroshima, 730-0052
Nishihara Nakamura Med Clinic /ID# 155999
Hiroshima, 731-0113
Hiroshima University Hospital /ID# 152319
Hiroshima, 734-8551
Hiroshima-Nishi Medical Center /ID# 161744
Hiroshima, 739-0651
Hiroshima Clinic /ID# 153614
Hiroshima
Hiroshima General Hosp W JP /ID# 152077
Hiroshima
Iwao Hospital /ID# 152306
Hita, 877-0012
Hitachi, Ltd., Hitachi Gen Hos /ID# 161748
Hitachi, 317-0077
Naganuma Municipal Hospital /ID# 152991
Hokkaido, 069-1332
Japanese Red Cross Kitami Hosp /ID# 153010
Hokkaido
Akashi City Hospital /ID# 150058
Hyōgo
Ashiya Municipal Hospital /ID# 150054
Hyōgo
Hyogo Prefectural Awaji Hosp /ID# 152237
Hyōgo
Hyogo Prefectural Kakogawa Med /ID# 152280
Hyōgo
Tokyo Dental College Ichikawa /ID# 154665
Ichikawa-shi, 272-8513
Iizuka Hospital /ID# 152186
Iizuka, 820-0018
Ikeda Municipal Hospital /ID# 152170
Ikeda, 563-8510
Nagasaki Prefecture Iki Hospit /ID# 154674
Iki, 811-5132
Nara Hosp Kinki Uni Fac Of Med /ID# 155895
Ikoma, 630-0227
Saiseikai Imabari Hospital /ID# 158100
Imabari, 799-1502
Ina Central Hospital /ID# 152144
Ina, 396-0033
Tokyo Med Uni Ibaraki Med Ctr /ID# 152121
Inashiki, 300-0332
Inuyama Chuo General /ID# 154672
Inuyama, 484-0066
Saitama Medical University Hos /ID# 152073
Iruma-gun, 350-0451
Saitama Medical University Hos /ID# 153616
Iruma-gun, 350-0451
Ise Red Cross Hospital /ID# 154670
Ise, 516-0008
Yamada Internal Medicine Clini /ID# 154786
Isesaki, 372-0048
Katakai Clinic /ID# 152163
Isesaki, 372-0813
Yawata Medical Center /ID# 152215
Ishikawa, 9230833
Matto Ishikawa Public Hospital /ID# 153638
Ishikawa
Kamiiwade Internal Med-Neuro /ID# 160802
Iwade, 649-6216
Iwaki Kyoritsu General Hosp /ID# 153617
Iwaki
Yoshioka Clinic /ID# 152305
Iwaki
Nishimi Medical Clinic /ID# 161752
Iwakuni, 741-0061
Kayanoki Internal Medicine Cli /ID# 152235
Izumiōtsu, 595-0046
Juntendo Univ Shizuoka Hosp /ID# 153615
Izunokuni-shi, 410-2295
Kawabata Internal Medicine Gas /ID# 153629
Joetsu-niigata, 942-0061
Mitoyo General Hospital /ID# 152185
Kagawa, 7691601
Nanpuh Hospital /ID# 153008
Kagoshima, Kagoshima-ken, 8928512
Konan Kakogawa Hospital /ID# 158102
Kakogawa
Shonan Kamakura General Hospital /ID# 152070
Kamakura-shi, Kanagawa, 247-8533
Yoshii Internal Medicine /ID# 158067
Kaminoyama, 999-3125
Fuji Clinic /ID# 152968
Kan’onjichō, 3440067
Kiyokawa Hospital /ID# 152156
Kanagawa, 166-0004
Nagase Medical Clinic /ID# 157498
Kanagawa, 213-0033
Hiratsuka City Hospital /ID# 154730
Kanagawa
Niwa Hospital /ID# 154762
Kanagawa
Kanazawa University Ho /ID# 152174
Kanazawa, Ishikawa-ken, 92086-41
Fujise Internal Medicine Clini /ID# 155886
Kashiwa, 277-0075
The Jikei Univ. Kashiwa Hosp. /ID# 152281
Kashiwa-shi, 277-0004
Fukuoka Tokushukai Medical Ctr /ID# 154654
Kasuga-shi, 816-0864
Kawase Clinic /ID# 152969
Kasugai, 486-0914
Sakamoto Internal Med Clinic /ID# 161745
Katori, 287-0001
Sekishindo Hospital /ID# 154653
Kawagoe, 350-1123
Saitama Medical Center, Saitama Medical University /ID# 153641
Kawagoe-shi, Saitama, 350-8550
Saiseikai Kawaguchi Gen. Hosp. /ID# 153631
Kawaguchi-saitama, 332-0021
Kawasaki Municipal Tama Hospit /ID# 152132
Kawasaki, 214-0021
St. Marianna Univ Hospital /ID# 152218
Kawasaki, 216-8511
Kanto Rosai Hospital /ID# 152202
Kawasaki-shi, Kanagawa
Nakano Clinic /ID# 165262
Kazuno, 018-5201
Kirishima Medical Center /ID# 152095
Kirishima, 899-5112
Kojima Clinic /ID# 152285
Kiryū, 376-0006
Kimitsu Chuo Hospital /ID# 152995
Kisarazu, 292-8535
Kawazoe Internal Medicine Clin /ID# 154789
Kishima-gun, 849-1113
Kishiwada Tokushukai Hospital /ID# 165260
Kishiwada, Osaka, 596-0042
JR Kyushu Hospital /ID# 152074
Kitakyushu, 800-0031
Kokura Kinen Hospital /ID# 152997
Kitakyushu, 802-0001
Iwamoto Internal Medical Clini /ID# 152994
Kitakyushu, 802-0832
Kitasato University Medical Ce /ID# 150053
Kitamoto, 364-0026
Kobe University Hospital /ID# 153004
Kobe, Hyōgo, 650-0017
Kobe City Medical Center West /ID# 152304
Kobe, 653-0013
Kobe City Medical Center West /ID# 153005
Kobe, 653-0013
Kobe Asahi Hospital /ID# 152173
Kobe, 653-0801
Kochi Red Cross Hospital /ID# 159450
Kochi, 780-0062
Hosoda Clinic /ID# 152978
Kofu, 400-0067
Tokyo Jikei Daisan Hospital /ID# 155896
Komae-shi, Tokyo, 201-8601
Cosmos Clinic /ID# 152298
Kōriyama, 963-0209
Ishida Medical Clinic /ID# 152297
Kōriyama, 963-8023
Hanada Internal Medicine Clin /ID# 155785
Koshigaya, Saitam, 343-0015
Kumamoto Shinto General Hospital /ID# 152149
Kumamoto, Kumamoto, 8628655
National Hosp Org Kumamoto /ID# 154783
Kumamoto, 860-0008
Seto Hospital /ID# 150056
Kumamoto, 861-3455
Kawasaki Medical School Hosp /ID# 152119
Kurashiki, 701-0114
Kurashiki Central Hospital /ID# 154656
Kurashiki, 710-0052
Mizushima Kyodo Hospital /ID# 152302
Kurashiki, 712-8567
Fukura Clinic /ID# 165273
Kurayoshi
National Hosp Org Kure Med Cen /ID# 152071
Kure, Hiroshima, 737-0023
Kurihara Central Hospital /ID# 152295
Kurihara, 228-0014
Kuroishi Hospital /ID# 153636
Kuroishi-aomori, 036-0541
Kurume University Hospital /ID# 152099
Kurume-shi, Fukuoka, 830-0011
Hori Internal Medicine Clinic /ID# 152291
Kushiro, 085-0005
Kyoto Prefect Univ Med /ID# 152236
Kyoto, Kyoto, 602-8566
Kyoto Prefect Univ Med /ID# 152981
Kyoto, Kyoto, 602-8566
JP Red Cross Kyoto Daiichi Hos /ID# 152221
Kyoto, Kyoto, 605-0981
Kyoto City Hospital /ID# 152188
Kyoto, 604-8845
Nakajima Clinic /ID# 157480
Kyoto, 606-8203
Aiseikai Yamashina Hospital /ID# 152100
Kyoto, 607-8086
Sawa Clinic /ID# 162881
Kyoto, 607-8344
NHO Kyoto Medical Center /ID# 152224
Kyoto, 612-0861
Otokoyama Hospital /ID# 153017
Kyoto, 6148366
Kagawa University Hospital /ID# 154731
Kyoto, 615-8256
Machida Municipal Hospital /ID# 152184
Machida, 194-0023
Gunma University Hospital /ID# 154669
Maebashi, Gunma, 371-8511
Maebashi Red Cross Hospital /ID# 154707
Maebashi
Kagawa Rosai Hospital /ID# 152131
Marugame, 763-0013
Kono Naika clinic /ID# 152094
Marugame, 763-0081
Masuda Red Cross Hospital /ID# 153635
Masuda-shimane, 698-0003
Shinmatsudo Central General Ho /ID# 154668
Matsudo, 270-0034
Matsudo City Hospital /ID# 154666
Matsudo, 271-0064
Matsudo City Hospital /ID# 154764
Matsudo, 271-0064
Gibo Hepatorogy Clinic /ID# 154763
Matsumoto, 399-0036
Shinshu University Hospital /ID# 153632
Matsumoto-shi, Nagano, 〒390-8621
Matsuyama Red Cross Hosp /ID# 152271
Matsuyama, Ehime, 7900826
Ehime Prefectural Central Hosp /ID# 154675
Matsuyama, 790-0024
Saiseikai Matsuyama Hospital /ID# 152270
Matsuyama, 791-8026
Tajiri Hospital /ID# 152320
Mimasaka, 707-0003
Kizawa Memorial Hospital /ID# 152096
Minokamo, 505-0034
Kyorin University Hospital /ID# 152990
Mitaka-shi, Tokyo, 181-8611
Sumiyoshi Clinic Hospital /ID# 152093
Mito, 310-0844
Miyakonojo National Hospital /ID# 153007
Miyakonojō, 885-0014
Miyazaki Medical Center Hospit /ID# 152154
Miyazaki, 880-0003
Hepatopia Nishikohdai-naika /ID# 154788
Miyazaki, 880-0941
Haga Red Cross Hospital /ID# 152085
Mooka, Tochigi, 321-4306
Matsushita Memorial Hospital /ID# 154655
Moriguchi-shi, 570-0096
Iwate Medical University Hospital /ID# 152076
Morioka, Iwate, 020-8505
MC Ryokumeikai Yoshida Clinic /ID# 150055
Morioka, 020-0832
Abe Saien Clinic /ID# 153014
Morioka, 200024
Aichi Medical University Hosp /ID# 152220
Nagakute, Aichi-ken, 4801195
Nagano Prefectural Kiso Hospit /ID# 152276
Nagano, 397-0001
Kimura Clinic /ID# 152146
Nagano
Tachikawa Medical Center /ID# 154784
Nagaoka, 940-0052
Nagasaki University Hospital /ID# 152233
Nagasaki, Nagasaki, 852-8501
Jap Red Cross Nagasaki Genbaku /ID# 152300
Nagasaki, 852-8104
Jap Red Cross Nagasaki Genbaku /ID# 152303
Nagasaki, 852-8104
Nagoya City University Hospital /ID# 153642
Nagoya, Aichi-ken, 467-8602
NHO Nagoya Medical Center /ID# 152294
Nagoya, 460-0001
Kita Hospital /ID# 158065
Nagoya, 462-0804
Japanese Red Cross Nagoya Daii /ID# 158099
Nagoya
Nakatsu Municipal Hospital /ID# 154673
Nakatsu, 871-0011
Kouseiren Namerikawa Hospital /ID# 154706
Namerikawa, 936-8585
Nara City Hospital /ID# 152189
Nara, 530-0025
Miyagiwa Internal Med Clinic /ID# 155887
Nara, 631-0011
Nara Prefectural Hospital /ID# 152234
Nara
Japanese Red Cross Narita Hosp /ID# 155894
Narita-shi, Chiba, 286-8523
Tani Internal Medicine Clinic /ID# 157448
Nayoro, 096-0018
Kameda Clinic /ID# 162879
Nishinomiya, 662-0841
Rinko Clinic /ID# 159449
Nishinomiya, 662-0922
Ooka Clinic /ID# 162880
Nishinomiya, 663-8124
The Hospital of Hyogo College of Medicine /ID# 157482
Nishinomiya-shi, Hyōgo, 663-8501
Meiwa Hospital /ID# 152134
Nishinomiya, Hyogo, 663-8186
Kikkoman General Hospital /ID# 152139
Noda, Chiba, 278-0005
Noshiro Yamamoto Med. Assoc. /ID# 154785
Noshiro, 016-0151
Obihiro Dai-ichi Hospital /ID# 152238
Obihiro, 080-0014
Odawara Municipal Hospital /ID# 154761
Odawara, 250-8558
Eguchi Hospital /ID# 152292
Ogi, 845-0032
Tokai University Oiso Hospital /ID# 157456
Ōiso
Oita Red Cross Hospital /ID# 152289
Ōita, 870-0033
Oita Midical Center /ID# 154737
Ōita, 870-0263
Oita Prefectural Hospital /ID# 165261
Ōita, 870-0855
Mori Internal Medicine Clinic /ID# 157446
Ōita, 870-0952
Aso Shoukaki-naika /ID# 164142
Ōita, 879-4412
Okayama University Hospital /ID# 152287
Okayama, Okayama-ken, 700-8558
Okayama Saiseikai Outpatient Center Hospital /ID# 150057
Okayama, 700-0013
Kawaguchi Internal Medicine Cl /ID# 152301
Okayama
Heartlife Hospital /ID# 153619
Okinawa
Ome Municipal General Hospital /ID# 153653
Ōme, 198-0042
Omuta City Hospital /ID# 152222
Omuta, 836-0861
Nishimura Clinic /ID# 154790
Omuta
Kita-harima Medical Center /ID# 153003
Ono, 675-1327
Onomichi Central General Hospi /ID# 152150
Onomichi
Osaka Saiseikai Nakatsu Hospital /ID# 155967
Osaka, Osaka, 530-0012
Osaka Red Cross Hospital /ID# 152190
Osaka, Osaka, 543-8555
Osaka City University Hospital /ID# 152160
Osaka, Osaka, 545-0051
Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 152279
Osaka, Osaka, 550-0006
Tazuke Kofukai Foundation /ID# 152182
Osaka, 530-8480
Gokeikai Osaka Kaisei Hospital /ID# 153644
Osaka, 532-0003
Otemae Hospital /ID# 152987
Osaka, 540-0008
Center Clinic /ID# 161746
Osaka, 540-0025
Osaka Police Hospital /ID# 154781
Osaka, 543-0035
NTT WEST Osaka Hospital /ID# 157445
Osaka, 543-0042
Mori Clinic /ID# 157489
Osaka, 546-0042
Kansai Denryoku Hospital /ID# 155966
Osaka, 553-0003
Tamai Clinic /ID# 164951
Osaka, 557-0002
Osaka General Medical Center /ID# 160907
Osaka, 558-8558
Kansai Medical Univ Takii Hosp /ID# 152130
Osaka, 570-8507
Osaka Hospital /ID# 152168
Osaka, 572-0854
Asai Orthopedic /ID# 153015
Osaka
Osaka Gen Hosp West Railway /ID# 155962
Osaka
Nasu Red Cross Hospital /ID# 152972
Ōtawara, 324-0062
Shiga Univ Med Science Hosp /ID# 153628
Ōtsu, Shiga, 520-2192
Otsu City Hospital /ID# 152155
Ōtsu, 520-0804
Japanese Red Cross Otsu Shiga /ID# 153640
Ōtsu
Ryugasaki Saiseikai Hospital /ID# 153639
Ryūgasaki
Nakayama Medical Clinic /ID# 157481
Saga, 849-0921
Imari Arita Kyoritsu Hospital /ID# 152321
Saga, 849-4141
Saga Medical Center Koseikan /ID# 152989
Saga-shi, SAGA, 840-8571
Japanese Red Cross Sagamihara /ID# 153000
Sagamihara, 252-0157
Fuchinobe General Hospital /ID# 152996
Sagamihara, 252-0206
Sagamino Hospital /ID# 154676
Sagamihara, 252-0206
Saitama Citizens Medical Ctr /ID# 162882
Saitama, 331-0054
Honda Internal Clinic /ID# 157497
Saitama, 349-0115
Bellland General Hospital /ID# 152148
Sakai, 599-8247
Osaka Rosai Hospital /ID# 152286
Sakaishi
Nihonkai General Hospital /ID# 152973
Sakata-shi, 998-0828
Takayanagi Clinic /ID# 152975
Sakura, 385-0053
Hyogo-Chuo National Hospital /ID# 157441
Sanda, 669-1515
Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 152165
Sapporo, Hokkaido, 060-0033
Sapporo Medical Univ Hosp /ID# 152992
Sapporo, Hokkaido, 060-8543
Hokkaido University Hospital /ID# 152982
Sapporo, 060-8648
IMS Sapporo Digestive Disease /ID# 154733
Sapporo, 063-0842
Sapporo Hokuyu Hospital /ID# 154709
Sapporo
Sasebo Chuo Hospital /ID# 154657
Sasebo, 857-1195
Tohoku University Hospital /ID# 152980
Sendai, Miyagi, 980-8574
JR Sendai Hospital /ID# 152240
Sendai, 980-0022
Sendai Kousei Hospital /ID# 152181
Sendai, 980-0873
Sendai Red Cross Hospital /ID# 160908
Sendai, 982-0801
Shinmen Internal Medicine Clin /ID# 152172
Sennan, 590-0504
Tosei General Hospital /ID# 154710
Seto, 489-8642
Japanese Red Cross Medical Center /ID# 152219
Shibuya-ku, Tokyo, 150-8935
NHO Shizuoka Medical Center /ID# 155897
Shimizu-sho
Shimonoseki Medical Center /ID# 165263
Shimonoseki, 750-0061
Dokkyo Medical University Hosp /ID# 152153
Shimotsuga, 321-0293
Dokkyo Medical University Hosp /ID# 153656
Shimotsuga, 321-0293
Anzunomori Clinic /ID# 157491
Shimotsuke, 329-0432
Jichi Medical University Hospital /ID# 152069
Shimotsuke-shi, Tochigi, 329-0498
Showa University Hospital /ID# 153618
Shinagawa-ku, Tokyo
Tokyo Medical University Hospital /ID# 152288
Shinjuku-ku, Tokyo, 160-0023
Tokyo Women's Medical University Hospital /ID# 152290
Shinjuku-ku, Tokyo, 162-8666
Tokyo Women's Medical University Hospital /ID# 156383
Shinjuku-ku, Tokyo, 162-8666
About this study
Official title: Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1
The main objective of this study is to evaluate the safety and effectiveness of paritaprevir/ritonavir/ombitasvir used for patients infected with HCV genotype 1 in daily practice in Japan.
- Conditions
- Chronic Hepatitis C Virus
- Keywords
- Hepatitis C Virus (HCV), Paritaprevir, Ombitasvir, Ritonavir, Genotype 1
- Medical subject headings
- Hepatitis C, Chronic, Hepatitis C
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Chronic infection of hepatitis C virus (HCV) Genotype 1 (GT1) | Participants with confirmed chronic hepatitis C genotype 1, receiving paritaprevir/ritonavir/ombitasvir according to standard of care and in line with the current local label |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of Participants with Sustained Virologic Response (SVR12)
Hepatitis C virus ribonucleic acid less than the lower limit of quantification 12 weeks after the last dose of study drug.
Measured: 12 weeks after the last dose of study drug
Secondary outcomes (3)
Percentage of Participants with Virologic Failure After Treatment
Confirmed quantifiable hepatitis C virus ribonucleic acid (HCV RNA) at the end of 12 week treatment but subsequent viremia with HCV RNA greater than or equal to the lower limit of quantitation during follow-up period of 24 weeks after treatment.
Measured: Post-treatment 24 weeks
Percentage of Participants with Sustained Virologic Response (SVR24)
Hepatitis C virus ribonucleic acid less than the lower limit of quantification 24 weeks after the last dose of study drug.
Measured: 24 weeks after the last dose of study drug
Percentage of Participants with Virologic Failure During Treatment
HCV RNA levels reach less than the lower limit of quantitation (LLOQ), then increase to greater than or equal to the LLOQ at any point during treatment.
Measured: Up to Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Dec 2015 (estimated)
- Study start5 Jan 2016
- Primary completion28 Feb 2019
- Study completion28 Feb 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Hepatitis C VirusStudies of the same condition, open and under way.
- More trials run by AbbVieThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 3,043 participants (actual)
Sponsor and investigators
- Lead sponsor
- AbbVie
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- AbbVie Inc., Study director, AbbVie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02629172
- Sponsor's protocol ID
- P15-336
- Status last verified
- Feb 2020
- First submitted
- 10 Dec 2015
- Last updated
- 24 Feb 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 24 Feb 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1
- ClinicalTrials.gov ID
- NCT02629172
- Acronym / sponsor ID
- P15-336
- Conditions
- Chronic Hepatitis C Virus
- Keywords
- Hepatitis C Virus (HCV), Paritaprevir, Ombitasvir, Ritonavir, Genotype 1
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 3,043 participants (actual)
- Lead sponsor
- AbbVieIndustry (pharma, biotech, devices)
- Study start
- 5 Jan 2016 (actual)
- Primary completion
- 28 Feb 2019 (actual)
- Study completion
- 28 Feb 2019 (actual)
- First posted
- 14 Dec 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main objective of this study is to evaluate the safety and effectiveness of paritaprevir/ritonavir/ombitasvir used for patients infected with HCV genotype 1 in daily practice in Japan.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Chronic infection of hepatitis C virus (HCV) Genotype 1 (GT1) | – | –Participants with confirmed chronic hepatitis C genotype 1, receiving paritaprevir/ritonavir/ombitasvir according to standard of care and in line with the current local label |
Who may qualify
- Ages
- Up to 120 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Chronic Hepatitis C
Key inclusion criteria (1 listed)
- HCV genotype 1 patients treated with paritaprevir/ritonavir/ombitasvir in daily practice
Key exclusion criteria (1 listed)
- Patients who have been previously treated with paritaprevir/ritonavir/ombitasvir
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Percentage of Participants with Sustained Virologic Response (SVR12)
Time frame: 12 weeks after the last dose of study drug
Hepatitis C virus ribonucleic acid less than the lower limit of quantification 12 weeks after the last dose of study drug.
3 secondary outcomes
Percentage of Participants with Virologic Failure After Treatment
Time frame: Post-treatment 24 weeks
Percentage of Participants with Sustained Virologic Response (SVR24)
Time frame: 24 weeks after the last dose of study drug
Percentage of Participants with Virologic Failure During Treatment
Time frame: Up to Week 12
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Feb 2020.
- clinical study report synopsisLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for Chronic Hepatitis C Virus
RecruitingObservational study
Evaluation of Patients With Liver Disease
Hepatitis D, Hepatitis C
Active, not recruitingPhase 4
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Diabetes Mellitus, Hepatitis C, Chronic
RecruitingObservational study
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Chronic Liver Disease and Cirrhosis, Liver Cancer
Active, not recruitingPhase 4
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Hepatitis C, Chronic, Pregnancy; Infection
Enrolling by invitationObservational study
Comparative Autoantibody and Immunologic Cell Marker Study
Autoimmune Diseases, Lupus Erythematosus, Systemic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
AbbVie Inc. study director
AbbVie
388 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Hepatitis C Virus, run by AbbVie at 388 sites in Japan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 388 sites in Japan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of Participants with Sustained Virologic Response (SVR12) (time frame: 12 weeks after the last dose of study drug). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2020.